(MENAFN- America News Hour) Research Nester assesses the growth of global dialysis market over the forecast period, i.e., 2023-2033 and evaluates its future prospects. Increasing prevalence of chronic kidney disease across the world to drive market growth. As per the Centers for Disease Control and Prevention, in the U.S 15% of adults i.e., 1 in 7 adults or 37 million Americans suffered from chronic kidney disease in 2021.
Research Nester's recent market research analysis on “dialysis market : Global Demand Analysis & Opportunity Outlook 2033” delivers a detailed competitors analysis and a detailed overview of the global dialysismarket in terms of market segmentation by type, product and service, end-user, and by region.
Increasing Number of Cases of Chronic Kidney Disease to Drive Growth of the Global
Dialysis
Market
The global dialysismarket is estimated to grow majorly on account of rising in kidney failure cases and the practice of unhealthy lifestyles with increased stress and tensions. Chronic kidney failure or chronic kidney disease occurs on account of damage to the kidneys which will lead to functional abnormality. The failure of kidneys ceases blood filtration to remove toxins and the toxins get accumulated in the body leading to multi-organ dysfunction. This may gradually lead to heart attack, high blood pressure, heart arrest, or early death. In these cases, dialysis helps to prolong life expectancy and improve kidney disease.
It is estimated that nearly 11% of the population across the world is living with chronic kidney disease as of 2022.
The market research report on global dialysisencompasses an in-depth analysis of the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends. These analyses help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future. Additionally, the growth opportunities exposed by the market is poised to gain significant momentum in the next few years.
Access our detailed report at:
By type, the global dialysismarket is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment is to garner a highest revenue by the end of 2033 by growing at a significant CAGR over the forecast period. Dialysis is effective in toxic elimination and increasing homecare adoption in end-stage renal disease and rising high blood pressure patients are anticipated to propel the market growth.
As per the data from the Centers for Disease Control and Prevention, the U.S records 670,000 deaths in the year 2020 on account of high blood pressure.
By region, the North America dialysismarket is to generate the highest revenue by the end of 2033. This growth is anticipated by growing healthcare expenditure, elevating demand for the development of new products, and rising disposable income.
As per the CMS, in 2020, the U.S national health expenditure increased by 9.7% to reach USD 4.1 trillion or USD 12,350 per person.
The research is global in nature and covers detailed analysis on the dialysismarket in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising of global dialysismarket size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
This report also provides the existing competitive scenario of some of the key players of the global dialysismarket which includes company profiling of Baxter International, Inc., Nikkiso Co., Ltd., MEDIVATORS, Inc., NIPRO Corporation, Diaverum AB, B. Braun Melsungen AG, DaVita, Inc., Asahi Kasei Corporation, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global dialysismarket that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919